| Thomas Theodore Schmidt, MD | |
|
1 Albert Cree Dr, Rutland, VT 05701 | |
| (802) 775-4266 | |
| (802) 786-0611 |
| Full Name | Thomas Theodore Schmidt |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 12 Years |
| Location | 1 Albert Cree Dr, Rutland, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154696250 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 4301109204 (Michigan) | Secondary |
| 2084N0400X | Psychiatry & Neurology - Neurology | 042.0014345 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rutland Regional Medical Center | Rutland, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rutland Hospital Inc | 7214846377 | 157 |
News Archive
Researchers at Cardiff University have discovered a new type of killer T-cell that offers hope of a "one-size-fits-all" cancer therapy.
Scientists at Osaka University developed a new drug treating skin lesions in tuberous sclerosis complex (TSC), a rare intractable disease, a world first.
"Women less than 55 years old are more likely to have their ACS misdiagnosed in the ER than men, and they have higher risk of death," adds first author Dr. Nadia Khan, associate professor of Medicine, UBC. "The public and physicians need to be aware of this problem."
Eighty-four percent of patients suffering from chronic tennis elbow (lateral epicondylar tendinopathy) reported significantly less pain and elbow tenderness at six months following platelet rich plasma (PRP) treatment, according to results from the largest, multi-center study, to date, on PRP and tennis elbow, presented today at the 2013 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
SkinMedica, Inc. and New York University announced today that they have entered into a global license agreement to develop novel products to address skin hyperpigmentation based on technology invented at NYU.
› Verified 8 days ago
| Entity Name | Rutland Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083678833 PECOS PAC ID: 7214846377 Enrollment ID: O20040913000323 |
News Archive
Researchers at Cardiff University have discovered a new type of killer T-cell that offers hope of a "one-size-fits-all" cancer therapy.
Scientists at Osaka University developed a new drug treating skin lesions in tuberous sclerosis complex (TSC), a rare intractable disease, a world first.
"Women less than 55 years old are more likely to have their ACS misdiagnosed in the ER than men, and they have higher risk of death," adds first author Dr. Nadia Khan, associate professor of Medicine, UBC. "The public and physicians need to be aware of this problem."
Eighty-four percent of patients suffering from chronic tennis elbow (lateral epicondylar tendinopathy) reported significantly less pain and elbow tenderness at six months following platelet rich plasma (PRP) treatment, according to results from the largest, multi-center study, to date, on PRP and tennis elbow, presented today at the 2013 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
SkinMedica, Inc. and New York University announced today that they have entered into a global license agreement to develop novel products to address skin hyperpigmentation based on technology invented at NYU.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Theodore Schmidt, MD 1 Albert Cree Dr, Rutland, VT 05701-4674 Ph: (802) 775-4266 | Thomas Theodore Schmidt, MD 1 Albert Cree Dr, Rutland, VT 05701 Ph: (802) 775-4266 |
News Archive
Researchers at Cardiff University have discovered a new type of killer T-cell that offers hope of a "one-size-fits-all" cancer therapy.
Scientists at Osaka University developed a new drug treating skin lesions in tuberous sclerosis complex (TSC), a rare intractable disease, a world first.
"Women less than 55 years old are more likely to have their ACS misdiagnosed in the ER than men, and they have higher risk of death," adds first author Dr. Nadia Khan, associate professor of Medicine, UBC. "The public and physicians need to be aware of this problem."
Eighty-four percent of patients suffering from chronic tennis elbow (lateral epicondylar tendinopathy) reported significantly less pain and elbow tenderness at six months following platelet rich plasma (PRP) treatment, according to results from the largest, multi-center study, to date, on PRP and tennis elbow, presented today at the 2013 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
SkinMedica, Inc. and New York University announced today that they have entered into a global license agreement to develop novel products to address skin hyperpigmentation based on technology invented at NYU.
› Verified 8 days ago
Erica M. Sweet, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Albert Cree Dr, Rutland, VT 05701 Phone: 802-775-4266 Fax: 802-786-0611 | |
Saeed Ahmed, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 160 Allen St, Rutland, VT 05701 Phone: 802-775-7111 Fax: 802-773-4471 | |
Evelyn Susan Gerretson, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 215 Stratton Rd, Rutland, VT 05701 Phone: 802-773-3386 Fax: 802-773-4578 | |
Dr. Richard P. Lango, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 73 Center St, Rutland, VT 05701 Phone: 802-775-7778 Fax: 802-775-7775 | |
Matthew D Sommons, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 160 Allen St, Rutland, VT 05701 Phone: 802-747-3715 Fax: 802-773-4471 | |
Dr. Stephen M Brittain, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 254 Stratton Rd, Rutland, VT 05701 Phone: 802-775-4266 Fax: 802-786-0611 |